Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

666 Complete vs. culprit-only strategy in older MI patients with multi-vessel disease

View through CrossRef
Abstract Aims The revascularization strategy to pursue in older myocardial infarction (MI) patients with multivessel disease (MVD) is currently unknown. For this reason, while waiting for the results of dedicated trials, we sought to compare a complete vs. a culprit-only strategy in older MI patients by merging data from four registries. Methods and results The inclusion criteria for the target population of the present study were: (i) age ≥75 years; (ii) MI (STE or NSTE); (iii) MVD; and (iv) successful treatment of culprit lesion. Propensity scores (PS) were derived using logistic regression (backwards stepwise selection, P < 0.2. The primary outcome was all-cause mortality. Secondary outcomes were cardiovascular (CV) death, MI, major bleeding. Multivariable adjustment included the PS and inverse probability of treatment weighting (IPTW). The Kaplan–Meier plots were weighted for IPT. Among 2087 patients included, 1362 (65%) received culprit-only treatment whereas 725 (35%) complete revascularization. The mean age was 81.5 years, while mean Follow-up was 419 ± 284 days. Seventy-four patients (10%) died in the complete group and 223 in the culprit-only one (16%). The adjusted cumulative 1-year mortality was 9.7% in the complete and 12.9% in the culprit-only group (adjusted HR: 0.67, 95% CI: 0.50–0.89). Complete revascularization was associated with lower incidence of CV death (adjusted HR: 0.68, 95% CI: 0.48–0.95) and MI (adjusted HR: 0.67, 95% CI: 0.48–0.95). Conclusions Culprit-only is the default strategy in older MI patients with MVD. In our analysis, complete revascularization was associated with lower all-cause and CV mortality and with a lower MI rate.
Title: 666 Complete vs. culprit-only strategy in older MI patients with multi-vessel disease
Description:
Abstract Aims The revascularization strategy to pursue in older myocardial infarction (MI) patients with multivessel disease (MVD) is currently unknown.
For this reason, while waiting for the results of dedicated trials, we sought to compare a complete vs.
a culprit-only strategy in older MI patients by merging data from four registries.
Methods and results The inclusion criteria for the target population of the present study were: (i) age ≥75 years; (ii) MI (STE or NSTE); (iii) MVD; and (iv) successful treatment of culprit lesion.
Propensity scores (PS) were derived using logistic regression (backwards stepwise selection, P < 0.
2.
The primary outcome was all-cause mortality.
Secondary outcomes were cardiovascular (CV) death, MI, major bleeding.
Multivariable adjustment included the PS and inverse probability of treatment weighting (IPTW).
The Kaplan–Meier plots were weighted for IPT.
Among 2087 patients included, 1362 (65%) received culprit-only treatment whereas 725 (35%) complete revascularization.
The mean age was 81.
5 years, while mean Follow-up was 419 ± 284 days.
Seventy-four patients (10%) died in the complete group and 223 in the culprit-only one (16%).
The adjusted cumulative 1-year mortality was 9.
7% in the complete and 12.
9% in the culprit-only group (adjusted HR: 0.
67, 95% CI: 0.
50–0.
89).
Complete revascularization was associated with lower incidence of CV death (adjusted HR: 0.
68, 95% CI: 0.
48–0.
95) and MI (adjusted HR: 0.
67, 95% CI: 0.
48–0.
95).
Conclusions Culprit-only is the default strategy in older MI patients with MVD.
In our analysis, complete revascularization was associated with lower all-cause and CV mortality and with a lower MI rate.

Related Results

Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical activi...
Some way over expanding the plaque volume up high, there is a risk on myocardial salvage
Some way over expanding the plaque volume up high, there is a risk on myocardial salvage
Abstract Background Slow flow phenomenon is impaired coronary flow during percutaneous coronary intervention (PCI) in abs...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Optical coherence tomography assessment of macrophages accumulation in non-ST-segment elevation acute coronary syndromes
Optical coherence tomography assessment of macrophages accumulation in non-ST-segment elevation acute coronary syndromes
Aims To investigate in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) the prevalence and the features of optical coherence tomography (OCT)-d...
Guideline Recommendations for Non-Culprit Lesion Intervention in Stemi: When to Go Beyond the Culprit
Guideline Recommendations for Non-Culprit Lesion Intervention in Stemi: When to Go Beyond the Culprit
Background: Non-culprit coronary lesion management of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a controversial topic in inte...

Back to Top